grey arrow to go to previous Omnicell webpage or forward to next Omnicell pageBack to Press Release

August 27, 2019

Omnicell to Present at the 2019 Wells Fargo Securities Healthcare Conference

Download PDF

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aug. 27, 2019-- Omnicell, Inc. (NASDAQ:OMCL) a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that Randall Lipps, founder, chairman, president and CEO, and Peter Kuipers, executive vice president and CFO, will be presenting at the 2019 Wells Fargo Securities Healthcare Conference at the Westin Copley Place, Boston, MA.

Date:Wednesday, September 4, 2019
Time: 04:10 p.m. ET
Location:Westin Copley Place, Boston, Mass.
Availability: The audio-webcast of the live presentation may be accessed by visiting:

Following the conference, a replay of the audio-webcast will be archived for 90 days on the Omnicell website.

About Omnicell

Since 1992, Omnicell has been inspired to create safer and more efficient ways to manage medications across all care settings. Through its industry-leading medication management platform that spans the continuum of care, Omnicell is developing a vision for a fully automated infrastructure, powered by a cloud data platform that supports improved patient care, fewer errors, enhanced safety, and new opportunities for growth.

Omnicell's vision for the Autonomous Pharmacy integrates a comprehensive set of solutions across three key areas: automation solutions designed to digitize and streamline workflows; intelligence that provides actionable insights to better understand medication usage and improve pharmacy supply chain management; and work - expert services that serve as an extension of pharmacy operations to support improved efficiency, regulatory compliance, and patient outcomes.

Over 5,500 facilities worldwide use Omnicell automation and analytics solutions to help increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. More than 40,000 institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell's innovative medication adherence solutions designed to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.

To learn more about Omnicell and its Autonomous Pharmacy vision, please visit


Source: Omnicell, Inc.

Peter Kuipers
Chief Financial Officer
800-850-6664, ext. 6180